No Detail Found!

Dyslipidemia as a risk factor for developing hypertension and cardiovascular disease in females of reproductive age

Author(s)
Beenish William Department of Biotechnology, Kinnaird College for Women,Lahore,Pakistan
Iqra Riaz Department of Biotechnology, Kinnaird College for Women,Lahore,Pakistan
Sundus Mubashir Department of Biotechnology, Kinnaird College for Women,Lahore,Pakistan
Komal Aslam Department of Biochemistry. Kinnaird College for Women,Lahore,Pakistan
Aysha Saeed Department of Biotechnology, Kinnaird College for Women,Lahore,Pakistan; Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences,Lahore,Pakistan
Irum Anjum Department of Biotechnology, Kinnaird College for Women,Lahore,Pakistan
Abstract
Obesity is the foremost contributor to the global load of chronic disability and disease acting as risk factor for diabetes, cardiovascular disease, certain types of cancer, stroke and hypertension which ultimately lead to premature death. The current research was conducted to estimate the correlation of lipid profile in all BMI categories (underweight, normal, overweight & obese) with development of hypertension and cardiovascular disease (CVD) in females of reproductive age. Hormonal changes during reproductive age of the females affect their metabolism in ways that increase their risk of developing cardiovascular diseases (e.g. arthrosclerosis). It has been found that women are 4-8 times prone to develop CVD than any other disease thus making it the leading cause of death in females of this age group. A total number of 80 females aged between 25-45 years categorized according to BMI categories (underweight, normal, overweight and obese) were recruited for the current study. Their anthropometric and demographic information was collected using a carefully designed questionnaire while their lipid profile was estimated using corresponding kits by Human® Germany. Lipid profile estimation revealed that obese individuals had very high levels of cholesterol and triglycerides, as much as 300mg/dL and 281mg/dL, respectively, significantly higher than the described normal range. Obese individuals were also found to have very low concentration of HDL, i.e. below 39mg/dL. The statistical analysis using SPSS analysis indicates a significant correlation (p=0.000) between BMI and all the parameters of lipid profile i.e. cholesterol, triglycerides, HDL and LDL. A direct relationship between dyslipidemia and hypertension has also been a significant finding of the current study, corresponding to past reports. The overall results indicated an increasing trend towards hypertension and cardiovascular disease with the increasing BMI and more importantly due to impaired lipid profile i.e. dyslipidemia. The present study point towards a strong need to create awareness among masses to not only monitor but maintain their lipid profiles and optimum BMI to avoid being at risk of hypertension and eventually various fatal cardiovascular diseases.
Publication Details
Page(s) 139-147
DOI DOI not available
Published Journal: Journal of Natural & Applied Sciences Pakistan, Volume: 1, Issue: 2, Year: 2019

Request the full text from PASTIC

Keywords
Obesity, cholesterol, BMI, High density lipoprotein, Dyslipidemia, Triglycerides, Low density lipoprotein, cardiovascular disease (CVD), hypertension (ht)
References
Bener A.,Al-Suwaidi J.,Al-Jaber K.,Al-Marri S.,Dagash M. H.,Elbagi I.-E. A. .2004 .The prevalence of hypertension and its associated risk factors in a newly developed country. Saudi medical journal, 25(7) : 918-922.
Berhanu S.,Gemeda A,C. A .2019 .Dyslipidemia and associated factors among women using hormonal contraceptives in Harar town, Eastern Ethiopia. BioMed central research notes 12:120, : .
Brown ,Higgins M.,Donato K. A.,Rohde F. C.,Garrison R.,Obarzanek E.,Horan M. .2000 .Body mass index and the prevalence of hypertension and dyslipidemia. Obesity research, 8(9) : 605-619.
Bucher K.,Friedlander Y.,Kaplan E.,Namboodiri K.,Kark J.,Eisenberg S.,Rao D. .1988 .Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel-the Lipid Research Clinics Program. Genetic epidemiology, 5(1) : 17-33.
Daniels T. F.,Killinger K. M.,Michal J. J.,Wright Jr,Jiang R. W.,Z. R. W. .2009 .Lipoproteins, cholesterol homeostasis and cardiac health. International journal of biological sciences, 5, (5) : 474.
Dupuis J.,Larson M. G.,Vasan R. S.,Massaro J. M.,Lipinska P. W.,Benjamin I.,E. J. I. .2005 .Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis, 182(2) : 307-314.
Eren E.,Yilmaz N.,Aydin O. .2012 .High density lipoprotein and it's dysfunction. The open biochemistry journal, 6 : 78.
Francine K.,Welty M. D. .2001 .Cardiovascular Disease and Dyslipidemia in Women. Archives of internal medicine. , 161(4) : 514-522.
Hall J. E.,do Carmo J. M.,da Silva A. A.,Wang Z.,Hall M. E. .2015 .Obesityinduced hypertension: interaction of neurohumoral and renal mechanisms. Circulation research, 116(6) : 991-1006.
Heiland E. G. .2018 .Cardiovascular risk factor profiles in the development and progression of physical limitation in old age: a population-based study: Inst för neurobiologi. , : .
Jafar T.,Levey A.,White F.,Gul A.,Jessani S.,Khan A.,Chaturvedi N. .2004 .Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan. Diabetic medicine, 21(7) : 716-723.
Jiang S.,Lu W.,Zong X.,Ruan H.,Liu Y. .2016 .Obesity and hypertension. Exp Ther Med, 12(4) : 2395-9.
Juliaty A.,Sari D. M.,Daud D.,Lisal J. S. .2015 .Relationship between blood pressure and lipid profile on obese children. Am J Health Res, 3(4) : 198-202.
Kraja A. T.,Rao D. C.,Weder A. B.,Cooper R.,Curb J. D.,Hanis C. L.,Quertermous T. .2005 .Two major QTLs and several others relate to factors of metabolic syndrome in the family blood pressure program. Hypertension, 46(4) : 751-757.
Kumalasari L.,Hilmi A. Y.,Priyandoko D. .2017 .The application of multiple intelligence approach to the learning of human circulatory system. Paper presented at the Journal of Physics: Conference Series., : .
Leon B. M.,Maddox T. M. .2015 .Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World journal of diabetes, 6(13) : 1246.
Lima-Oliveira G.,Valentim C. D.,Guidi G. C. .2017 .Lipid profile, changes in laboratory prescriptions are necessary. Journal of clinical lipidology, 11(3) : 768-769.
Lin H.-F.,Boden-Albala B.,Juo S.,Park N.,Rundek T.,Sacco R. L. .2005 .Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia, 48(10) : 2006-2012.
Luo B.,Du L.,Li J.,Pan B.,Xu J.,Chen J.,Zhang F. .2010 .Heritability of metabolic syndrome traits among healthy younger adults: a population based study in China. Journal of medical genetics, 47(6) : 415-420.
Mannino D. M.,Thorn D.,Swensen A.,Holguin F. .2008 .Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. European Respiratory Journal, 32(4) : 962-969.
Nigam P. .2011 .Serum lipid profile: fasting or non-fasting?. Indian Journal of Clinical Biochemistry, 26(1) : 96-97.
Nuttall F. Q. .2015 .Body mass index: obesity, BMI, and health: a critical review. Nutrition today, 50(3) : 117.
Ozner M. .2010 .The Great American Heart Hoax: Lifesaving Advice Your Doctor Should Tell You about Heart Disease Prevention (but Probably Never Will): BenBella Books. , : .
Pankow J. S.,Folsom A. R.,Cushman M.,Borecki I. B.,Hopkins P. N.,Eckfeldt J. H.,Tracy R. P. .2001 .Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis, 154(3) : 681-689.
Pencina M. J.,D'Agostino R. B.,Zdrojewski T.,Williams K.,Thanassoulis G.,Furberg C. D.,Sniderman A. D. .2015 .Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. European journal of preventive cardiology, 22(10) : 1321-1327.
Petrák O.,Zelinka T.,Štrauch B.,Rosa J.,Šomlóová Z.,Indra T.,Widimský Jr,J. Jr .2016 .Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension. Journal of human hypertension, 30(1) : 35.
Pimenta A. M.,Kac G.,Gazzinelli A.,CorrêaOliveira A.,Velásquez-Meléndez R.,G. R. .2008 .Association between central obesity, triglycerides and hypertension in a rural area in Brazil. , 90(6) : 419-425.
Rankinen T.,Sarzynski M. A.,Ghosh S.,Bouchard C. .2015 .Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors? Circulation research. , 116(5) : 909-922.
Retterstol L.,Eikvar L.,Berg K. .2003 .A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis, 169(2) : 279-282.
Saleem F.,Dua J.,Hassali A.,Shafie A. .2010 .Hypertension in Pakistan: time to take some serious action. British journal of general practice, 60(576) : 449-450.
Santos-Gallego C. G.,Ibanez B.,Badimon J. J. .2008 .HDL-cholesterol: Is it really good?: Differences between apoA-I and HDL. , 76(4) : 443-452.
Santos R. D.,Gidding S. S.,Hegele R. A.,Cuchel M. A.,Barter P. J.,Watts G. F.,Defesche J. C. .2016 .Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. The lancet Diabetes & endocrinology, 4(10) : 850-861.
Segura J.,Ruilope L. M. .2007 .Obesity, essential hypertension and reninangiotensin system. Public health nutrition, 10(10A) : 1151-1155.
Stabouli S.,Kotsis V.,Rizos Z.,Toumanidis S.,Karagianni C.,Constantopoulos A.,Zakopoulos N. .2009 .Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatric nephrology, 24(8) : 1545-1551.
Thayer J. F.,Yamamoto S. S.,Brosschot J. F. .2010 .The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. International journal of cardiology, 141(2) : 122-131.
Wang C. C. L.,Hess C. N.,Hiatt W. R.,Goldfine A. B. .2016 .Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes-mechanisms, management, and clinical considerations. Circulation, 133(24) : 2459.
Zalesin K. C.,Franklin B. A.,Miller W. M.,Peterson E. D.,McCullough P. A. .2008 .Impact of obesity on cardiovascular disease. Endocrinology and metabolism clinics of North America, 37(3) : 663-684.
0

Citations

0

Downloads

48

Views